Table 3:
Primary results, intent-to-treat framework
| Estimate (95% CI) | P-value | |
|---|---|---|
| Systolic Blood Pressure | ||
| Placebo treatment (n = 75) | Reference | |
| Education treatment (n = 74) | −3.46 (−11.45, 4.54) | 0.39 |
| Filtration treatment (n = 76) | 0.25 (−7.73, 8.24) | 0.95 |
| Diastolic Blood Pressure | ||
| Placebo treatment (n = 75) | Reference | |
| Education treatment (n = 74) | −1.00 (−5.42, 3.42) | 0.65 |
| Filtration treatment (n = 76) | −0.58 (−4.97, 3.81) | 0.79 |
| Forced Vital Capacity | ||
| Placebo treatment (n = 31) | Reference | |
| Education treatment (n = 30) | −0.09 (−0.24, 0.07) | 0.28 |
| Filtration treatment (n = 40) | 0.01 (−0.14, 0.16) | 0.89 |
| Forced Expiratory Volume in 1 Second | ||
| Placebo treatment (n = 31) | Reference | |
| Education treatment (n = 30) | −0.11 (−0.24, 0.02) | 0.10 |
| Filtration treatment (n = 40) | 0.01 (−0.11, 0.13) | 0.90 |
| Forced Expiratory Volume in 1 Second / Forced Vital Capacity Ratio | ||
| Placebo treatment (n = 31) | Reference | |
| Education treatment (n = 30) | −0.02 (−0.05, 0.00) | 0.06 |
| Filtration treatment (n = 40) | 0.00 (−0.03, 0.02) | 0.71 |
Models adjusted for baseline (Winter 1) outcome; model includes nested random term: participant:home:cohort:area. CI = confidence interval